Copyright
©The Author(s) 2015.
World J Hepatol. Nov 18, 2015; 7(26): 2631-2635
Published online Nov 18, 2015. doi: 10.4254/wjh.v7.i26.2631
Published online Nov 18, 2015. doi: 10.4254/wjh.v7.i26.2631
Figure 1 Wnt-/-β-catenin signaling pathway.
A: APC protein, axin, and GSK-3 that forms the complex destruction of the β-catenin protein in the proteasome; B: Wnt binds to Frizzled and LRP receptors, dissolving the destruction-complex, which results in an increase of β-catenin in the cytoplasm and nucleus. β-catenin forms a binding complex with the transcription factor LEF-/-TCF proteins to promote the activation of target genes. LRP: Lipoprotein receptor; Dvl: Dishevelled; APC: Adenomatous polyposis coli; GSK3: Glycogen synthase kinase 3; LET/TCF: Lymphoid enhancer factor/T-cell factor.
- Citation: Waisberg J, Saba GT. Wnt-/-β-catenin pathway signaling in human hepatocellular carcinoma. World J Hepatol 2015; 7(26): 2631-2635
- URL: https://www.wjgnet.com/1948-5182/full/v7/i26/2631.htm
- DOI: https://dx.doi.org/10.4254/wjh.v7.i26.2631